879 related articles for article (PubMed ID: 16234999)
1. Bone health in urban midlife Malaysian women: risk factors and prevention.
Lim PS; Ong FB; Adeeb N; Seri SS; Noor-Aini MY; Shamsuddin K; Hapizah N; Mohamed AL; Mokhtar A; Wan HW
Osteoporos Int; 2005 Dec; 16(12):2069-79. PubMed ID: 16234999
[TBL] [Abstract][Full Text] [Related]
2. [Effects of estrogen therapy on bone mass in postmenopausal women with osteopenia].
Insua A; Negri A; Zanchetta JR
Medicina (B Aires); 1995; 55(5 Pt 1):408-14. PubMed ID: 8728770
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of low central bone mineral density in a Bulgarian female referral population: a pilot study.
Boyanov MA
Rheumatol Int; 2006 Apr; 26(6):523-9. PubMed ID: 16082556
[TBL] [Abstract][Full Text] [Related]
4. A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis.
Wimalawansa SJ
Am J Med; 1998 Mar; 104(3):219-26. PubMed ID: 9552083
[TBL] [Abstract][Full Text] [Related]
5. [Study on risk factors of cardiovascular disease and the status of bone mineral density in women with hypoestrogenism].
Zhao F; Guo XT; Cheng Y; Yang ZF; Liu HP
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):734-9. PubMed ID: 24406128
[TBL] [Abstract][Full Text] [Related]
6. Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis.
McClung MR; Wasnich RD; Recker R; Cauley JA; Chesnut CH; Ensrud KE; Burdeska A; Mills T;
J Bone Miner Res; 2004 Jan; 19(1):11-8. PubMed ID: 14753731
[TBL] [Abstract][Full Text] [Related]
7. Increased reduction in bone density and skin thickness in postmenopausal women taking long-term corticosteroid therapy: a suggested role for estrogen add-back therapy.
Baron YM; Brincat MP; Galea R
Climacteric; 1999 Sep; 2(3):189-96. PubMed ID: 11910596
[TBL] [Abstract][Full Text] [Related]
8. Effect of parity on bone mineral density among postmenopausal Saudi Arabian women.
Sadat-Ali M; Al-Habdan I; Al-Mulhim AA; El-Hassan AY
Saudi Med J; 2005 Oct; 26(10):1588-90. PubMed ID: 16228061
[TBL] [Abstract][Full Text] [Related]
9. Familial resemblance of bone mineral density (BMD) and calcaneal ultrasound attenuation: the BMD in mothers and daughters study.
Danielson ME; Cauley JA; Baker CE; Newman AB; Dorman JS; Towers JD; Kuller LH
J Bone Miner Res; 1999 Jan; 14(1):102-10. PubMed ID: 9893071
[TBL] [Abstract][Full Text] [Related]
10. The benefit of hormone replacement therapy on bone mass is greater at the vertebral body than posterior processes or proximal femur.
Duan Y; Tabensky A; DeLuca V; Seeman E
Bone; 1997 Nov; 21(5):447-51. PubMed ID: 9356739
[TBL] [Abstract][Full Text] [Related]
11. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
Gallagher JC; Fowler SE; Detter JR; Sherman SS
J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
[TBL] [Abstract][Full Text] [Related]
12. Determinants of bone mineral density in older postmenopausal Chinese women.
Khoo CC; Woo J; Leung PC; Kwok A; Kwok T
Climacteric; 2011 Jun; 14(3):378-83. PubMed ID: 21401441
[TBL] [Abstract][Full Text] [Related]
13. Effect of soy isoflavone extract supplements on bone mineral density in menopausal women: meta-analysis of randomized controlled trials.
Taku K; Melby MK; Takebayashi J; Mizuno S; Ishimi Y; Omori T; Watanabe S
Asia Pac J Clin Nutr; 2010; 19(1):33-42. PubMed ID: 20199985
[TBL] [Abstract][Full Text] [Related]
14. Total calcium intake is associated with cortical bone mineral density in a cohort of postmenopausal women not taking estrogen.
Suzuki Y; Whiting SJ; Davison KS; Chilibeck PD
J Nutr Health Aging; 2003; 7(5):296-9. PubMed ID: 12917743
[TBL] [Abstract][Full Text] [Related]
15. Effect of Milk Powder Supplementation with Different Calcium Contents on Bone Mineral Density of Postmenopausal Women in Northern China: A Randomized Controlled Double-Blind Trial.
Chen Y; Xiao Y; Xie B; Zhang Q; Ma X; Li N; Liu M; Zhang Q
Calcif Tissue Int; 2016 Jan; 98(1):60-6. PubMed ID: 26438518
[TBL] [Abstract][Full Text] [Related]
16. Effect of teriparatide [rhPTH(1-34)] on BMD when given to postmenopausal women receiving hormone replacement therapy.
Ste-Marie LG; Schwartz SL; Hossain A; Desaiah D; Gaich GA
J Bone Miner Res; 2006 Feb; 21(2):283-91. PubMed ID: 16418784
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonates for prevention of postmenopausal osteoporosis.
Ravn P
Dan Med Bull; 2002 Feb; 49(1):1-18. PubMed ID: 11894721
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait.
Al-Shoumer KA; Nair V
Arch Osteoporos; 2012; 7():147-53. PubMed ID: 23225292
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of hormone replacement therapy on bone mineral density and axial transmission ultrasound measurements in cortical bone.
Knapp KM; Blake GM; Spector TD; Fogelman I
Osteoporos Int; 2003 Jun; 14(4):289-94. PubMed ID: 12730793
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of estrogen treatment on bone mineral density of the spine, hip, wrist and total body in late postmenopausal women.
Kohrt WM; Birge SJ
Osteoporos Int; 1995 May; 5(3):150-5. PubMed ID: 7655174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
